GL1X · GenesisL1 explorer

MolNFT v1 · #167361 · protein

Human lrh-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator tif-2

6VIF · Nuclear receptor subfamily 5 group a member 2: “Human lrh-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator tif-2”. X-ray diffraction, 1 ligand (QY4), 3 pockets (best druggability 0.87). MolNFT v1 #167361…

PDB
6VIF
Type
protein
Length
246 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor subfamily 5 group a member 2; Nuclear receptor coactivator 2
UniProt
O00482, Q15596
Ligands
QY4
Pockets
3 · best druggability 0.87

Structure

x-ray diffraction · 2 distinct chains · 73% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor subfamily 5 group a member 2protein23573% helix, 3% strandO00482
BNuclear receptor coactivator 2protein1173% helix, 0% strandQ15596

Ligands and binding sites

  • QY4 · N-[(8beta,11alpha,12alpha)-8-{[methyl(phenyl) amino]methyl}-1,6:7,14-dicycloprosta-1(6),2,4,7(14)-tetraen-11-yl]sulfuric diamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14410.870.9336QY4
2890.580.8621empty
3640.350.7713empty

Interfaces

1 interface between chains.

  • A–B · 605 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 6VIF · Human LRH-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator… · the same entry in another collection · chain A against A, TM-score 1.00
  • O00482 · AlphaFold monomer V2.0 prediction for nuclear receptor subfamily 5 group a member 2… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.